Trial Profile
Effect of Fampridine treatment on clinical response and habitual mobility in patients with Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2017
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 May 2017 New trial record